5-amino-6-(5-phosphoribosylamino)uracil reductase, 5-amino-6-(5-phosphoribosylamino)uracil reductase, 7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase

5-amino-6- (5-phosphoribosylamino) uracil reductase: I loko o ka enzymology, kahi 5-amino-6- (5-phosphoribosylamino) uracil reductase (EC 1.1.1.193 ) kahi enzyme e catalyzed i ka hopena kemika 5-amino-6- (5-phosphoribitylamino) uracil + NADP + 5-amino-6- (5-phosphoribosylamino) uracil + NADPH + H +
5-amino-6- (5-phosphoribosylamino) uracil reductase: I loko o ka enzymology, kahi 5-amino-6- (5-phosphoribosylamino) uracil reductase (EC 1.1.1.193 ) kahi enzyme e catalyzed i ka hopena kemika 5-amino-6- (5-phosphoribitylamino) uracil + NADP + 5-amino-6- (5-phosphoribosylamino) uracil + NADPH + H +
7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase: 7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase (EC 4.3.1.32 , FO synthase ) a me 5-amino-6- (D-ribitylamino) uracil — L-tyrosine 4-hydroxyphenyl transferase (EC 2.5.1.147 ) Hoʻohui pū ʻia nā ʻelua mau enzyme e hoʻokō i ka synthesist o FO, kahi mua o Coenzyme F420. ʻO ko lākou mau inoa ʻōnaehana 5-amino-5- (4-hydroxybenzyl) -6- (D-ribitylimino) -5,6-dihydrouracil ammonia-lyase (7,8-didemethyl-8-hydroxy-5-deazariboflavin-hoʻokumu) a 5-amino-6- (D-ribitylamino) uracil: L-tyrosine, 4-hydroxyphenyl transferase pakahi. Hoʻopili ka ʻenima i nā hopena kemika i lalo: (2.5.1.147) 5-amino-6- (D-ribitylamino) uracil + L-tyrosine + S-adenosyl-L-methionine = 5-amino-5- (4-hydroxybenzyl) -6- (D-ribitylimino) - 5,6-dihydrouracil + 2-iminoacetate + L-methionine + 5'-deoxyadenosin (4.3.1.32) 5-amino-5- (4-hydroxybenzyl) -6- (D-ribitylimino) -5,6-dihydrouracil + S-adenosyl-L-methionine = 7,8-didemethyl-8-hydroxy-5 -deazariboflavin + NH 3 + L-methionine + 5'-deoxyadenosine
Lumazine synthase: Lumazine synthase (EC 2.5.1.78 , 6,7-dimethyl-8-ribityllumazine synthase , 6,7-dimethyl-8-ribityllumazine synthase 2 , 6,7-dimethyl-8-ribityllumazine synthase 1 , lumazine synthase 2 , lumazine synthase 1 , type I lumazine synthase , type II lumazine synthase , RIB4 , MJ0303 , RibH , Pbls , MbtLS , RibH1 protein , RibH2 protein , RibH1 , RibH2 ) kahi enzyme me ka inoa ʻōnaehana 5-amino-6- (D-ribitylamino) uracil butanedionetransferase . Hoʻopili kēia enzyme i ka hopena kemika i lalo 1-deoxy-L-glycero-tetrulose 4-phosphate + 5-amino-6- (D-ribitylamino) uracil 6,7-dimethyl-8- (D-ribityl) lumazine + 2 H 2 O + phosphate
Lumazine synthase: Lumazine synthase (EC 2.5.1.78 , 6,7-dimethyl-8-ribityllumazine synthase , 6,7-dimethyl-8-ribityllumazine synthase 2 , 6,7-dimethyl-8-ribityllumazine synthase 1 , lumazine synthase 2 , lumazine synthase 1 , type I lumazine synthase , type II lumazine synthase , RIB4 , MJ0303 , RibH , Pbls , MbtLS , RibH1 protein , RibH2 protein , RibH1 , RibH2 ) kahi enzyme me ka inoa ʻōnaehana 5-amino-6- (D-ribitylamino) uracil butanedionetransferase . Hoʻopili kēia enzyme i ka hopena kemika i lalo 1-deoxy-L-glycero-tetrulose 4-phosphate + 5-amino-6- (D-ribitylamino) uracil 6,7-dimethyl-8- (D-ribityl) lumazine + 2 H 2 O + phosphate
ʻO Pyrimidinedione: ʻO Pyrimidinediones kahi papa o nā mea hoʻohui kemika i hōʻike ʻia e ke apo pyrimidine i pani ʻia me ʻelua mau hui carbonyl.
AICA ribonucleotide: 5-Aminoimidazole-4-carboxamide ribonucleotide ( AICAR ) kahi mea waena i ka hanauna o ka inosine monophosphate. ʻO AICAR kahi analog o adenosine monophosphate (AMP) i hiki ke hoʻonāukiuki i ka hana kinase protein AMP-i hilinaʻi ʻia (AMPK). Ua hoʻohana ʻia ʻo AICAR i ka lāʻau lapaʻau e mālama a pale aku ai i ka ʻeha ʻana o ka ischemic cardiac. Ua hoʻohana mua ʻia ka lāʻau i loko o nā makahiki 1980 ma ke ʻano he mālama i ke kahe o ke koko i ka puʻuwai i ka wā o ke ʻoki. I kēia manawa, ua hōʻike ʻia ka lāʻau lapaʻau ma ke ʻano he hiki ke mālama ʻia no ka maʻi kō ma o ka hoʻonui ʻana i ka hana metabolic o nā aʻa ma o ka hoʻololi ʻana i ke ʻano kino o ka mākala.
5'-Phosphoribosyl-4-carboxy-5-aminoimidazole: ʻO 5'-Phosphoribosyl-4-carboxy-5-aminoimidazole kahi mea waena i ka hoʻokumu ʻana i nā purine.
5-Aminoimidazole ribotide: ʻO 5'-Phosphoribosyl-5-aminoimidazole kahi mea waena i ka hoʻokumu ʻana o nā purine. No laila, he waena waena ia ma ke ala adenine, a synthesized ʻia mai 5'-phosphoribosylformylglycinamidine na AIR synthetase.
5-Aminoimidazole ribotide: ʻO 5'-Phosphoribosyl-5-aminoimidazole kahi mea waena i ka hoʻokumu ʻana o nā purine. No laila, he waena waena ia ma ke ala adenine, a synthesized ʻia mai 5'-phosphoribosylformylglycinamidine na AIR synthetase.
Aminolevulinic acid: ʻO ka acid-Aminolevulinic acid , kahi endogenous non-proteinogenic amino acid, ʻo ia ka hui mua i ke ala synthesist porphyrin, ke ala e alakaʻi ai i ka heme i nā māmela, a me ka chlorophyll i nā mea kanu.
Aminolevulinate transaminase: I ka enzymology, kahi aminolevulinate transaminase kahi enzyme e catalyzed i ka hopena kemika 5-aminolevulinate + pyruvate 4,5-dioxopentanoate + L-alanine
ʻO Delta-aminolevulinic acid dehydratase: ʻO Delta-aminolevulinic acid dehydratase ( porphobilinogen synthase , a i ʻole ALA dehydratase , a i ʻole aminolevulinate dehydratase ) kahi enzyme (EC 4.2.1.24 ) i loko o nā kānaka i hoʻopili ʻia e ka ʻohana ALAD . ʻO Porphobilinogen synthase (a i ʻole ALA dehydratase , a i ʻole aminolevulinate dehydratase ) synthesize porphobilinogen ma o ka asymmetric condencies o ʻelua mole mole o ka aminolevulinic acid. ʻO nā tetrapyrroles kūlohelohe āpau, e like me nā hemes, nā chlorophylls a me nā huaora B 12 , kaʻana like i ka porphobilinogen ma ke ʻano he precursor maʻamau. ʻO Porphobilinogen synthase ka prototype morpheein.
ʻO Delta-aminolevulinic acid dehydratase: ʻO Delta-aminolevulinic acid dehydratase ( porphobilinogen synthase , a i ʻole ALA dehydratase , a i ʻole aminolevulinate dehydratase ) kahi enzyme (EC 4.2.1.24 ) i loko o nā kānaka i hoʻopili ʻia e ka ʻohana ALAD . ʻO Porphobilinogen synthase (a i ʻole ALA dehydratase , a i ʻole aminolevulinate dehydratase ) synthesize porphobilinogen ma o ka asymmetric condencies o ʻelua mole mole o ka aminolevulinic acid. ʻO nā tetrapyrroles kūlohelohe āpau, e like me nā hemes, nā chlorophylls a me nā huaora B 12 , kaʻana like i ka porphobilinogen ma ke ʻano he precursor maʻamau. ʻO Porphobilinogen synthase ka prototype morpheein.
Aminolevulinic acid synthase: Aminolevulinic acid synthase ( ALA synthase , ALAS , a i ʻole delta-aminolevulinic acid synthase ) kahi enzyme (EC 2.3.1.37 ) e catalyze i ka synthesite o ka acid-aminolevulinic acid (ALA) ka mua mua ma mua o ka biosynthesis o nā tetrapyrroles āpau e like me nā hemes , nā cobalamins a me nā chlorophylls. Penei ka hopena: succinyl-CoA + glycine acid-aminolevulinic acid + CoA + CO 2
Aminolevulinic acid: ʻO ka acid-Aminolevulinic acid , kahi endogenous non-proteinogenic amino acid, ʻo ia ka hui mua i ke ala synthesist porphyrin, ke ala e alakaʻi ai i ka heme i nā māmela, a me ka chlorophyll i nā mea kanu.
Aminolevulinic acid: ʻO ka acid-Aminolevulinic acid , kahi endogenous non-proteinogenic amino acid, ʻo ia ka hui mua i ke ala synthesist porphyrin, ke ala e alakaʻi ai i ka heme i nā māmela, a me ka chlorophyll i nā mea kanu.
5-aminopentanamidase: I ka enzymology, he 5-aminopentanamidase (EC 3.5.1.30 ) kahi enzyme e catalyzed i ka hopena kemika 5-aminopentanamide + H 2 O 5-aminopentanoate + NH 3
5-aminopentanamidase: I ka enzymology, he 5-aminopentanamidase (EC 3.5.1.30 ) kahi enzyme e catalyzed i ka hopena kemika 5-aminopentanamide + H 2 O 5-aminopentanoate + NH 3
5-aminovalerate transaminase: I ka enzymology, he 5-aminovalerate transaminase kahi ʻenemema e catalyzed i ka hopena kemika 5-aminopentanoate + 2-oxoglutarate 5-oxopentanoate + L-glutamate
D-proline reductase (dithiol): I ka enzymology, kahi D-proline reductase (dithiol) kahi enzyme e catalyze i ka hopena kemika 5-aminopentanoate + lipoate D-proline + dihydrolipoate
D-proline reductase (dithiol): I ka enzymology, kahi D-proline reductase (dithiol) kahi enzyme e catalyze i ka hopena kemika 5-aminopentanoate + lipoate D-proline + dihydrolipoate
Mesalazine: ʻO Mesalazine , i kapa ʻia he mesalamine a i ʻole 5-aminosalicylic acid ( 5-ASA ), kahi lāʻau i hoʻohana ʻia e mālama ai i ka maʻi ʻōpū, me ke kolitis ulcerative a me ka maʻi o Crohn. Hoʻohana ʻia ia no ka maʻi haʻahaʻa a liʻiliʻi. Lawe ʻia e ka waha a pololei paha. ʻO nā formulated i lawe ʻia e ka waha e like me ka maikaʻi.
Mesalazine: ʻO Mesalazine , i kapa ʻia he mesalamine a i ʻole 5-aminosalicylic acid ( 5-ASA ), kahi lāʻau i hoʻohana ʻia e mālama ai i ka maʻi ʻōpū, me ke kolitis ulcerative a me ka maʻi o Crohn. Hoʻohana ʻia ia no ka maʻi haʻahaʻa a liʻiliʻi. Lawe ʻia e ka waha a pololei paha. ʻO nā formulated i lawe ʻia e ka waha e like me ka maikaʻi.
5-Aminotetrazole: ʻO 5-Aminotetrazole kahi hui kūmole me ka HN 4 CNH 2 . He paʻa keʻokeʻo ia i hiki ke kiʻi ʻia i nā ʻano anhydrous a hydrated.
5-aminovalerate transaminase: I ka enzymology, he 5-aminovalerate transaminase kahi ʻenemema e catalyzed i ka hopena kemika 5-aminopentanoate + 2-oxoglutarate 5-oxopentanoate + L-glutamate
Hoʻopaʻa inoa pūʻulu: I ka ʻepekema ʻepekema, hoʻopaʻa leo ʻia nā hui i hoʻopaʻa inoa ʻia a i ʻole hoʻopaʻa inoa pūʻulu pūʻulu ( GCR ) i kekahi mau ʻano hoʻopā'ālua akā pili e pili ana i ka pāpaho media. ʻO ka mea mua, i hoʻohana ʻia i ka 6250 bpi magnetic tape mai ka 1973, kahi pāʻālua hoʻoponopono hewa i hui pū ʻia me ka lōʻihi o ka lōʻihi o ka holo ʻana (RLL) i loko o ka pūʻulu o nā code modulation. ʻO nā mea ʻē aʻe ʻokoʻa pā hōkū keyframe ʻokoʻa a me nā kiʻina hana hoʻopāpā floppy disk i hoʻohana ʻia i kekahi mau microcomputers a hiki i ka hopena o 1980. He ʻano i hoʻoponopono ʻia ʻo GCR o kahi pāʻālua NRZI, akā pono me kahi kiʻekiʻena hoʻololi kiʻekiʻe.
Androstadienol: ʻO Androstadienol , a i ʻole androsta-5,16-dien-3β-ol , kahi steroid endogenous, pheromone, a me waena waena o nā kemika i loaʻa i ka hou o nā kāne a me nā wahine.
Dehydroandrolone: ʻO Dehydroandrolone ( DHA ), a i ʻole 5-dehydroandrolone ( 5-DHA ), i ʻike ʻia he isoandrostenolone , a ʻo androst-5-en-3α-ol-17-one , kahi endogenous androgen steroid hormone. ʻO ia ka 3α-epimer o dehydroepiandrolone a me ka 5 (6) -dehydrogenated a me ka non-5α-hoʻoliʻiliʻi analogue o androsterone (5α-androstan-3α-ol-17-one). Hana ʻia ka DHA a hūnā ʻia mai nā adrenal glands, a me nā androgens nāwaliwali e like me DHEA, androstenediol, a me androstenedione.
ʻO Androstenediol: ʻO Androstenediol , a i ʻole 5-androstenediol , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol , kahi androgen nāwaliwali endogenous a me ka estrogen steroid hormone a me waena ma ka biosynthesis o testosterone mai dehydroepiandrolone (DHEA). Pili loa ia iā androstenedione (androst-4-ene-3,17-dione).
Androstenediol 17β-ʻākeka: ʻO Androstenediol 17β-acetate , a i ʻole 5-androstenediol 17β-acetate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 17β-acetate , he mea hoʻohālikelike anabolic-androgenic steroid a me kahi ester androgen - kikoʻī, ʻo ka C17β acetate ester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - kahi i kūʻai ʻole ʻia aku ai.
Androstenediol 17β-ʻākeka: ʻO Androstenediol 17β-acetate , a i ʻole 5-androstenediol 17β-acetate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 17β-acetate , he mea hoʻohālikelike anabolic-androgenic steroid a me kahi ester androgen - kikoʻī, ʻo ka C17β acetate ester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - kahi i kūʻai ʻole ʻia aku ai.
Hoʻolaha Androstenediol: ʻO Androstenediol diacetate , a i ʻole 5-androstenediol 3β, 17β-diacetate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-diacetate , he mea hoʻohālikelike anabolic-androgenic steroid a he androgen ester - kikoʻī, ʻo C3β, 17β diacetate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - ʻaʻole ia i kūʻai aku ʻia. Ua hoʻohana ʻia ka lāʻau me ka kūleʻa e mālama i ka maʻi ʻaʻai umauma i nā wahine.
Androstenediol dipropionate: Androstenediol dipropionate , a i ʻole 5-androstenediol 3β, 17β-dipropionate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-dipropionate , he anabolic-androgenic steroid synthetic a me androgen ester - kikoʻī, ʻo ka diopopionate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - i kūʻai ʻia ma ʻEulopa, e like me Sepania, ʻItalia, a me ʻAukekulia.
Androstenediol 3β-ʻākeka: ʻO Androstenediol 3β-acetate , a i ʻole 5-androstenediol 3β-acetate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 3β-acetate , he mea hoʻohālikelike anabolic-androgenic steroid a me kahi ester androgen - kikoʻī, ʻo ka C3β acetate ester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - kahi i kūʻai ʻole ʻia aku ai.
Androstenediol sulfate: ʻO Androstenediol sulfate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β-sulfate , he endogenous, he steroid kūlohelohe a me nā metabolites urinary o androstenediol. sulfotransferase a hiki ke hoʻopau hou ʻia i androstenediol e ka steroid sulfatase.
Hoʻolaha Androstenediol: ʻO Androstenediol diacetate , a i ʻole 5-androstenediol 3β, 17β-diacetate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-diacetate , he mea hoʻohālikelike anabolic-androgenic steroid a he androgen ester - kikoʻī, ʻo C3β, 17β diacetate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - ʻaʻole ia i kūʻai aku ʻia. Ua hoʻohana ʻia ka lāʻau me ka kūleʻa e mālama i ka maʻi ʻaʻai umauma i nā wahine.
Androstenediol dipropionate: Androstenediol dipropionate , a i ʻole 5-androstenediol 3β, 17β-dipropionate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-dipropionate , he anabolic-androgenic steroid synthetic a me androgen ester - kikoʻī, ʻo ka diopopionate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - i kūʻai ʻia ma ʻEulopa, e like me Sepania, ʻItalia, a me ʻAukekulia.
Androstenediol 3β-ʻākeka: ʻO Androstenediol 3β-acetate , a i ʻole 5-androstenediol 3β-acetate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 3β-acetate , he mea hoʻohālikelike anabolic-androgenic steroid a me kahi ester androgen - kikoʻī, ʻo ka C3β acetate ester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - kahi i kūʻai ʻole ʻia aku ai.
Androstenediol sulfate: ʻO Androstenediol sulfate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β-sulfate , he endogenous, he steroid kūlohelohe a me nā metabolites urinary o androstenediol. sulfotransferase a hiki ke hoʻopau hou ʻia i androstenediol e ka steroid sulfatase.
Androstenediol'ākeka: E nānā paha ʻo Androstenediol acetate iā: Androstenediol 3β-acetate Androstenediol 17β-ʻākeka Androstenediol 3β, 17β-diacetate
Hoʻolaha Androstenediol: ʻO Androstenediol diacetate , a i ʻole 5-androstenediol 3β, 17β-diacetate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-diacetate , he mea hoʻohālikelike anabolic-androgenic steroid a he androgen ester - kikoʻī, ʻo C3β, 17β diacetate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - ʻaʻole ia i kūʻai aku ʻia. Ua hoʻohana ʻia ka lāʻau me ka kūleʻa e mālama i ka maʻi ʻaʻai umauma i nā wahine.
Androstenediol dipropionate: Androstenediol dipropionate , a i ʻole 5-androstenediol 3β, 17β-dipropionate , i kapa ʻia ʻo androst-5-ene-3β, 17β-diol 3β, 17β-dipropionate , he anabolic-androgenic steroid synthetic a me androgen ester - kikoʻī, ʻo ka diopopionate diester o 5-androstenediol (androst-5-ene-3β, 17β-diol) - i kūʻai ʻia ma ʻEulopa, e like me Sepania, ʻItalia, a me ʻAukekulia.
Androstenediol sulfate: ʻO Androstenediol sulfate , i ʻike ʻia ʻo androst-5-ene-3β, 17β-diol 3β-sulfate , he endogenous, he steroid kūlohelohe a me nā metabolites urinary o androstenediol. sulfotransferase a hiki ke hoʻopau hou ʻia i androstenediol e ka steroid sulfatase.
5-Androstenedione: ʻO 5-Androstenedione , i kapa ʻia ʻo androst-5-ene-3,17-dione , he prohormone ʻo testosterone. Pāpā ka World Anti-Doping Agency i kāna hoʻohana i nā mea haʻuki. I ka United States, he mea mālama ʻia.
5-IT: 5- (2-Aminopropyl) indole kahi indole a me ka phenethylamine derivative me nā hopena emphogenic. Ua hōʻike mua ʻia kāna hoʻomākaukau e Albert Hofmann i ka makahiki 1962. He lāʻau lapaʻau hoʻolālā kēlā i kūʻai ākea ʻia ma ke ʻano he lāʻau leʻaleʻa e nā mea kūʻai aku ma ka pūnaewele mai 2011.
Hemahema 5α-Reductase: 5α-Reductase deficit kahi autosomal recessive intersex ma muli o ka hoʻololi ʻana i ka SRD5A2 , kahi moʻokūʻauhau e hoʻopuni ana i ka ʻenema 5α-reductase ʻano 2. ʻO ka phenotype ka mea maʻamau e hana ai he pseudovaginal perineoscrotal hypospadias , kahi hoʻonohonoho o ka genitalia kūwaho o kahi pēpē. I ke ʻano, aia kēia hoʻonohonoho i waena o waena o nā genotypical kāne kāne genotypical, a me nā wahine genotypical kāne wahine, i ke ʻano a me ka helehelena. ʻO kahi ʻano maʻamau o ka maopopo ʻole o ka genital i hoʻokumu ʻia e ka undervirilization o nā kāne kāne kūpona ma muli o nā ʻano intersex like ʻole.
Pentation: I ka makemakika, ʻo pentation ka hyperoperation aʻe ma hope o ka tetration a ma mua o ka hexation. Hoʻomaopopo ʻia e like me ka tetration iterated (hou), e like me ka tetration e hōʻike ʻia exponentiation. He He aeaie hana i ho'ākāka 'ia me nā huahelu i ka a me ka b, kahi i ua tetrated ia iho, a b-1 manawa. ʻO kahi laʻana, e hoʻohana nei i ka nota hyperoperation no ka pentation a me ka tetration, ʻo ia hoʻi ka tetrating 2 iā ia iho i 2 manawa, a i ʻole . Hiki ke hoʻemi ʻia kēia i
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Mīkini multiaxis: ʻO ka mīkini Multiaxis kahi hana hana e hoʻopili i nā pono hana e neʻe i 4 a ʻoi paha mau ʻaoʻao a hoʻohana ʻia e hana i nā ʻāpana mai ka hao a i ʻole nā ​​mea ʻē aʻe e ka mīkini ʻana i nā mea he nui, e ka ʻoki ʻana i ka mokulele wai a i ʻole ka ʻoki ʻana i ka laser. Hana mua ʻia kēia ʻano mīkini me ka mīkini ma nā mīkini paʻakikī nui. Hana kēia mau mīkini ma 4, 5, 6, a me nā koʻi he 12 i kaohi ʻia ma o nā levers e kau ana ma nā pā kāmela. Hāʻawi nā papa kāmela i ka hiki ke kaohi i ka pono hana, ka pākaukau i hoʻopaʻa ʻia ai ka ʻāpana, a me ke kaʻapuni ʻana i ka mea hana a i ʻole ka ʻāpana i loko o ka mīkini. Ma muli o ka nui o nā mīkini a me ka paʻakikī paʻakikī i lawe i nā manawa he nui e hoʻonohonoho iā lākou no ka hana. I ka manawa e hoʻolauna ʻia ai ka mīkini ʻana i ka mīkini kamepiula ua hāʻawi ʻia kahi ala wikiwiki, ʻoi aku ka maikaʻi no ka mīkini ʻana i nā ʻāpana paʻakikī.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Hoʻopaʻa kiʻi: ʻO ka stabilizing kiʻi ( IS ) kahi ʻohana o nā ʻenehana e hōʻemi i ka blurring e pili ana me ka neʻe ʻana o kahi kāmela a i ʻole nā ​​kiʻi kiʻi ʻē aʻe i ka wā e hōʻike ai.
Decitabine: ʻO Decitabine , kūʻai ʻia ma lalo o ka inoa inoa Dacogen , hana ma ke ʻano he mea hōʻoki synthetic acid synthes . He lāʻau lapaʻau ia no ka mālama ʻana i nā syndrome myelodysplastic, kahi papa o nā kūlana kahi e hana ʻole ai kekahi mau hunaola koko, a no ka leukemia myeloid koʻikoʻi (AML). ʻO Chemically, he analog cytidine ia.
Decitabine: ʻO Decitabine , kūʻai ʻia ma lalo o ka inoa inoa Dacogen , hana ma ke ʻano he mea hōʻoki synthetic acid synthes . He lāʻau lapaʻau ia no ka mālama ʻana i nā syndrome myelodysplastic, kahi papa o nā kūlana kahi e hana ʻole ai kekahi mau hunaola koko, a no ka leukemia myeloid koʻikoʻi (AML). ʻO Chemically, he analog cytidine ia.
5-Aza-7-deazaguanine: 5-Aza-7-deazaguanine a i ʻole 2-aminoimidazo [1,2-a] [1,3,5] triazin-4 (1H) -one kahi kahua 5-Aza-7-deazapurine he isomer o guanine. Hoʻohana ʻia ia ma ke ʻano he nucleobase o hachimoji DNA, a pālua ʻia ia me 6-Amino-5-nitropyridin-2-one.
5-Aza-7-deazapurine: ʻO 5-Aza-7-deazapurine a i ʻole imidazo [1,2- a ] [1,3,5] triazine kahi hui ʻokanika heterocyclic aromatik i loko o kahi apo s-triazine i hoʻopili ʻia i ke apo imidazole. He isostere a me isomer o ka purine. Eia nō naʻe, i ka 5-aza-7-deazapurine, ʻaʻole paʻa ka N-9 o ke apo lima ʻelima me ka hydrogen. No laila ʻo 5-aza-7-deazapurine derivatives pono e loaʻa kahi excyclic substituent me ka pālua paʻa e nakinaki ai i ke koena kō. Loaʻa i kahi 5-Aza-7-deazapurine nucleosides he oxo, thioxo, a i ʻole kahi hui imine.
Decitabine: ʻO Decitabine , kūʻai ʻia ma lalo o ka inoa inoa Dacogen , hana ma ke ʻano he mea hōʻoki synthetic acid synthes . He lāʻau lapaʻau ia no ka mālama ʻana i nā syndrome myelodysplastic, kahi papa o nā kūlana kahi e hana ʻole ai kekahi mau hunaola koko, a no ka leukemia myeloid koʻikoʻi (AML). ʻO Chemically, he analog cytidine ia.
5N-Bicalutamide: ʻO 5 N -Bicalutamide , a i ʻole 5-azabicalutamide , he antiandrogen nonsteroidal (NSAA) ikaika loa i ʻike ʻia ma 2016. He hoʻololi ʻano kūkulu o ka bicalutamide ʻokoʻa ia mai iā ia wale nō e ke kuapo ʻana o kahi ʻāpana carbon me kahi nitrogen atom i hoʻokahi. o kona mau apo phenyl. Pēlā nō hoʻi i ka bicalutamide, hana ka lāʻau ma ke ʻano he antagonist koho o ka receptor androgen (AR). Eia nō naʻe, ʻokoʻa ka bicalutamide, he antagonist covalent hiki ke hoʻohuli ʻia a noho paʻa i ka mea loaʻa no kahi manawa lōʻihi loa. Ma muli o kēia ʻokoʻa, ua hoʻomaikaʻi maikaʻi ʻo 5 N -bicalutamide e pili ana i ka bicalutamide, me kahi o 150 mau pā i ʻoi aku ka kiʻekiʻe ma luna o ka AR (K i = 0.15 nM me 22.3 nM) a ma kahi o 20 mau pā hana nui i kāohi ʻia ( IC 50 = 15 nM kue 310 nM) o ka AR. Hoʻolālā ʻia nā hana ʻē aʻe o 5 N -bicalutamide i nā hunaola maʻi ʻaʻai prostate maʻamau a mutate a ke manaʻo ʻia nei e hiki i ka N -bicalutamide ke lanakila i ke kūʻē ʻana i nā antiandrogens o kēia manawa e hoʻohana ʻia i ka mālama ʻana i ka maʻi ʻaʻai prostate.
ʻO Azacitidine: ʻO Azacitidine , kūʻai ʻia ma lalo o ka inoa Vidaza me nā mea ʻē aʻe, kahi analog kemika o cytidine, kahi nucleoside ma DNA a me RNA. Hoʻohana ʻia ʻo Azacitidine a me kāna deoxy derivative, decitabine i ka mālama ʻana i ka myelodysplastic syndrome. Ua hana mua ʻia nā lāʻau ʻelua ma Czechoslovakia ma ke ʻano he chemotherapeutic agents no ka maʻi ʻaʻai.
ʻO Azacitidine: ʻO Azacitidine , kūʻai ʻia ma lalo o ka inoa Vidaza me nā mea ʻē aʻe, kahi analog kemika o cytidine, kahi nucleoside ma DNA a me RNA. Hoʻohana ʻia ʻo Azacitidine a me kāna deoxy derivative, decitabine i ka mālama ʻana i ka myelodysplastic syndrome. Ua hana mua ʻia nā lāʻau ʻelua ma Czechoslovakia ma ke ʻano he chemotherapeutic agents no ka maʻi ʻaʻai.
1-Diazidocarbamoyl-5-azidotetrazole: ʻO 1-Diazidocarbamoyl-5-azidotetrazole, i kapa pinepine ʻole ʻia me azidoazide azide , kahi hui inorganic heterocyclic me ke ʻano C 2 N 14 . He mea hoʻopā pahū ʻoi loa ia.
5B: E nānā paha ʻo 5B a i ʻole 5-B i:
Kaha Tally: ʻO nā māka Tally , i kapa ʻia nā māka hash , kahi ʻōnaehana helu unary. He ʻano helu lākou i hoʻohana ʻia no ka helu ʻana. Pono lākou i ka helu a helu ʻana paha i nā hopena e mau ana, e like me ka helu ma kahi pāʻani a haʻuki paha, no ka mea ʻaʻole pono e holoi ʻia a hoʻolei ʻia paha nā hopena waena.
5-Benzyloxytr Egyptamine: 5-Benzyloxytr Egyptamine ( 5-BT ), kahi pākana tryptamine e hana ma ke ʻano he agonist ma nā mea loaʻa he 5-HT 1D , 5-HT 2 a me 5-HT 6 serotonin, a me kahi mea kūʻē o TRPM8.
5β-Hoʻolaha: 5β-Reductase , a i ʻole Δ 4 -3-oxosteroid 5β-reductase (EC 1.3.1.3 , 3-oxo-Δ 4 -steroid 5β-reductase , androstenedione 5β-reductase , cholestenone 5β-reductase , cortisone 5β-reductase , cortisone Δ 4 -5β-reductase , steroid 5β-reductase , testosterone 5β-reductase , Δ 4 -3-ketosteroid 5β-reductase , Δ 4 -5β-reductase , Δ 4 -hydrogenase , 4,5β-dihydrocortisone: NADP + Δ 4 -oxidoreductase , 3-oxo-5β-steroid: NADP + Δ 4 -oxidoreductase ) kahi enzyme me ka inoa ʻōnaehana 5β-cholestan-3-one: NADP + 4,5-oxidoreductase . Hoʻopili kēia enzyme i ka hopena kemika i lalo (1) 5β-cholestan-3-one + NADP + cholest-4-en-3-one + NADPH + H + (2) 17,21-dihydroxy-5β-hāpai hānau-3,11,20-trione + NADP + cortisone + NADPH + H +
Bromodeoxyuridine: ʻO Bromodeoxyuridine kahi mea hoʻohālikelike nucleoside analogue me kahi hanana kemika e like me ka thymidine. Hoʻohana pinepine ʻia ʻo BrdU e hoʻopaʻa i ka hoʻonui ʻana o ka cell i nā pūnaewele ola a ua aʻo ʻia ma ke ʻano he radiosensitizer a me nā mea hana diagnostic i ka poʻe me ka maʻi ʻaʻai.
5-Bromouracil: ʻO 5-Bromouracil kahi mea i lawe ʻia o ka uracil e hana ma ke ʻano he antimetabolite a i ʻole analog kumu, e pani ana no ka thymine i loko o DNA, a hiki ke hoʻoulu i ka DNA mutation ma ke ʻano like me 2-aminopurine. Hoʻohana ʻia ia ma ke ʻano he mutagen hoʻokolohua, akā hoʻohana ʻia kāna deroxative deoxyriboside (5-bromo-2-deoxy-uridine) e mālama i nā neoplasms.
Bromodeoxyuridine: ʻO Bromodeoxyuridine kahi mea hoʻohālikelike nucleoside analogue me kahi hanana kemika e like me ka thymidine. Hoʻohana pinepine ʻia ʻo BrdU e hoʻopaʻa i ka hoʻonui ʻana o ka cell i nā pūnaewele ola a ua aʻo ʻia ma ke ʻano he radiosensitizer a me nā mea hana diagnostic i ka poʻe me ka maʻi ʻaʻai.
X-Gluc: ʻO X-Gluc kahi hui kemika me ka mole mole C 14 H 13 BrClNO 7 . Hoʻohana ʻia ia ma ke ʻano he reagent e ʻike i ka β-glucuronidase, kahi enzyme i hana ʻia e ka E. coli bacteria. Hoʻohana ʻia ia e ʻike i ka haumia o E. coli i ka meaʻai, ka wai a me ka maʻi mimi. Hoʻohui ʻia, hoʻohana nui ʻia ia i nā hoʻokolohua biology molekika e māka a koho i ka ʻōlelo o nā gen target (ʻōnaehana repost GUS).
5-Bromo-DMT: ʻO 5-Bromo-DMT ( 5-bromo- N , N -dimethyltr Egyptamine ) kahi alkaloid indole psychedelic i loaʻa ʻia i nā ʻupena Smenospongia aurea a me Smenospongia echina , a ʻo Verongula rigida ma kahi o 5,6-Dibromo-DMT a me ʻehiku mau alkaloid ʻē aʻe. . ʻO ia ka 5-bromo derivative o DMT, kahi psychedelic i loaʻa i nā mea kanu a me nā holoholona he nui.
5-Bromo-DMT: ʻO 5-Bromo-DMT ( 5-bromo- N , N -dimethyltr Egyptamine ) kahi alkaloid indole psychedelic i loaʻa ʻia i nā ʻupena Smenospongia aurea a me Smenospongia echina , a ʻo Verongula rigida ma kahi o 5,6-Dibromo-DMT a me ʻehiku mau alkaloid ʻē aʻe. . ʻO ia ka 5-bromo derivative o DMT, kahi psychedelic i loaʻa i nā mea kanu a me nā holoholona he nui.
Bromodeoxyuridine: ʻO Bromodeoxyuridine kahi mea hoʻohālikelike nucleoside analogue me kahi hanana kemika e like me ka thymidine. Hoʻohana pinepine ʻia ʻo BrdU e hoʻopaʻa i ka hoʻonui ʻana o ka cell i nā pūnaewele ola a ua aʻo ʻia ma ke ʻano he radiosensitizer a me nā mea hana diagnostic i ka poʻe me ka maʻi ʻaʻai.
5-Bromouracil: ʻO 5-Bromouracil kahi mea i lawe ʻia o ka uracil e hana ma ke ʻano he antimetabolite a i ʻole analog kumu, e pani ana no ka thymine i loko o DNA, a hiki ke hoʻoulu i ka DNA mutation ma ke ʻano like me 2-aminopurine. Hoʻohana ʻia ia ma ke ʻano he mutagen hoʻokolohua, akā hoʻohana ʻia kāna deroxative deoxyriboside (5-bromo-2-deoxy-uridine) e mālama i nā neoplasms.
5-Bromouridine: ʻO 5-Bromouridine kahi mea uridine i loaʻa me ka bromo i hakahaka ma ka ʻelima kalapona. Hoʻokomo ʻia ʻo BrUrd i loko o ka RNA a hiki ke ʻike ʻia me nā paleola a me ke kālailai ʻia e cytometry. Kuhi ia i ka hōʻino ʻia o DNA ma o ka hoʻololi kumu a hoʻonui i ka helu o nā hoʻololi.
Fusaric acid: ʻO ka Fusaric acid kahi derivative acid picolinic a me kahi antibiotic i hoʻokaʻawale mua ʻia mai ka fungus Fusarium heterosp hall .
5C: E nānā ʻo 5C a i ʻole 5c iā: 5C Nānā i ke kūlana: Kamupene, nā hoʻokūkū, nā mea kūʻai aku, nā mea hana, ke aniau 5-C, kahi hale paʻa ʻōpio ʻo Idaho no nā kānaka kūlana kiʻekiʻe CAL Cargo Air Lines pāʻālua IATA Hoʻopaʻa ʻo Chromosome Conformation iā Carbon Copy, a i ʻole 5C, kahi hoʻolōʻihi o ke kaʻina lawe like Chromosome (3C) i hoʻohana ʻia i nā genomics ʻO ka nīnau ʻelima ʻo Cambridge no nā kumu radio ʻElima Cs o Singapore, kahi manawa moʻomeheu e pili ana i ka materialism Kālā ʻelima keneta ʻO ka consortium o nā kolamu ʻo Claremont ʻelima ʻElima Hui (5C) Palekana ʻikepili hoʻoili uila ʻO ka iPhone 5C, kahi kelepona i hoʻolālā ʻia a kūʻai ʻia e Apple Inc. Ka Mea Hanohano 5C 5C, ke kiʻina hana no ka 1978 Kauka ʻO wai ka serial ʻO nā Pōhaku o ke Koko
ʻO ka Chlorogenic acid: ʻO ka Chlorogenic acid ( CGA ) ka ester o ka waikawa caffeic a me (-) - waikawa quinic, e hana nei ma ke ʻano he waena waena i ka biignintesis lignin. ʻO ka huaʻōlelo "chlorogenic acid" pili i kahi ʻohana polyphenol pili o nā esters, me nā waikawa hydroxycinnamic me ka waikawa quinic.
ʻO Neochlorogenic acid: ʻO Neochlorogenic acid a i ʻole he hui polyphenolic kūlohelohe i loaʻa i kekahi ʻano o nā hua maloʻo a me nā ʻano kumuwaiwai e like me nā peach. ʻIke pū ʻia ia i ka ʻai a ka Sunflower seed, Globe artichoke poʻo, Chicory [Red], Blueberry hapa-highbush, blueberry Highbush, Lovage, aʻa Burdock, a me blueberry Highbush. He isomer ʻo ia o ka chlorogenic acid; he lālā lāua ʻelua o ka papa ʻakika caffeoylquinic o nā mole.
5- (carboxyamino) imidazole ribonucleotide mutase: I loko o ka enzymology, kahi 5- (carboxyamino) imidazole ribonucleotide mutase kahi enzyme e catalyzed i ka hopena kemika 5-carboxyamino-1- (5-phospho-D-ribosyl) imidazole 5-amino-1- (5-phospho-D-ribosyl) imidazole-4-carboxylate
5-carboxymethyl-2-hydroxymuconate Delta-isomerase: I loko o ka enzymology, kahi 5-carboxymethyl-2-hydroxymuconate Delta-isomerase kahi enzyme e catalyzed i ka hopena kemika 5-carboxymethyl-2-hydroxymuconate 5-carboxy-2-oxohept-3-enedioate
5-carboxymethyl-2-hydroxymuconate Delta-isomerase: I loko o ka enzymology, kahi 5-carboxymethyl-2-hydroxymuconate Delta-isomerase kahi enzyme e catalyzed i ka hopena kemika 5-carboxymethyl-2-hydroxymuconate 5-carboxy-2-oxohept-3-enedioate
5-carboxymethyl-2-hydroxymuconate Delta-isomerase: I loko o ka enzymology, kahi 5-carboxymethyl-2-hydroxymuconate Delta-isomerase kahi enzyme e catalyzed i ka hopena kemika 5-carboxymethyl-2-hydroxymuconate 5-carboxy-2-oxohept-3-enedioate
5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase: I ka enzymology, he 5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase (EC 1.2.1.60 ) kahi enzyme e catalyzed i ka hopena kemika 5-carboxymethyl-2-hydroxymuconate semialdehyde + H 2 O + NAD + 5-carboxymethyl-2-hydroxymuconate + NADH + 2 H +
5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase: I ka enzymology, he 5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase (EC 1.2.1.60 ) kahi enzyme e catalyzed i ka hopena kemika 5-carboxymethyl-2-hydroxymuconate semialdehyde + H 2 O + NAD + 5-carboxymethyl-2-hydroxymuconate + NADH + 2 H +
Vitisin A (pyranoanthocyanin): ʻO Vitisin A kahi phenol kūlohelohe i loaʻa i nā waina ʻulaʻula. He pyranoanthocyanin ia.
ʻO 5-HT ka mea loaʻa: ʻO nā mea loaʻa ʻo 5-HT , nā mea loaʻa he 5-hydroxytr Egyptamine , a i ʻole nā mea loaʻa serotonin , kahi hui o nā mea loaʻa pū kekahi protein G a me nā kaha ion ligand-gated i loaʻa i nā ʻōnaehana kikowaena a me nā ʻaoʻao āpau. Hoʻopili lākou i nā neurotransmission excitatory a me inhibitory. Hoʻoulu ʻia nā mea hoʻolauna serotonin e ka neurotransmitter serotonin, e hana nei ma ke ʻano he ligand maoli.
Kaha ʻelima kāleka: ʻO ka huki ʻelima kāleka kahi ʻano poker i manaʻo ʻia ʻo ka maʻalahi maʻalahi o ka poker, a ʻo ia ke kumu no ka poker wikiō. ʻO ka hopena, ʻo ia ka mea mua loa i aʻo ʻia e nā mea pāʻani hou. Pāʻani ʻia ia i nā pāʻani home akā ʻaʻole pāʻani iki i ka casino a me nā pāʻani hoʻokūkū. Hāʻawi ʻia kahi ʻano ʻē e kekahi mau wahi pūnaewele, ʻoiai ʻaʻole makemake ʻia e like me nā ʻano ʻē aʻe e like me ka stud card ʻehiku a me Texas e paʻa iā lākou.
5-pūnaewele: I ke geometry, ʻo ka 5-cell kahi mea ʻehā dimensional i hoʻopaʻa ʻia e 5 mau tetrahedral cells. ʻIke ʻia ia he C 5 , pentachoron , pentatope , pentahedroid , a i ʻole tetrahedral pyramid . ʻO ia ka 4-simplex (Coxeter's polytope), ʻo ka maʻalahi maʻalahi hiki ke hoʻohui ʻia 4-polytope (ʻehā dimensional analogue o kahi paʻa Platonic), a like ia me ka tetrahedron i ʻekolu ana a me ka triangle i ʻelua ana. ʻO ka pentachoron kahi pyramid ʻehā dimensional me kahi kahua tetrahedral.
Waihona meli 5-pūnaewele: I loko o nā geometry Euclidean ʻehā dimensional, ka meli 4-simplex , 5-cell honeycomb a i ʻole honeycomb pentachoric-dispentachoric kahi waihona meli e hoʻopiha ana i kahi ākea. Hoʻokomo ʻia ia i nā ʻāpana 5 a hoʻoponopono ʻia i nā ʻaoʻao 5 i nā lākiō o 1: 1.
Pākuʻi 5-polytope: I ke geometry, he 5-polytope kākahu kahi polytope kālani ʻelima dimensional. Ma ka wehewehe ʻana, he vertex-transitive kahi lole like 5-polytope a kūkulu ʻia mai nā ʻaoʻao like 4-polytope.
Nickel (ʻĀpana ʻAmelika Hui Pū ʻIa): ʻO kahi nickel kahi ʻelima keneta keneta i kuʻi ʻia e ka United States Mint. I haku ʻia o 75% keleawe a me 25% nikela, ua hoʻopuka ʻia kēia ʻāpana mai ka makahiki 1866. ʻO ke anawaena he .835 iniha (21.21 mm) a ʻo kona mānoanoa he .077 iniha (1.95 mm). Ma muli o ka hoʻonui kālā ʻana, hoʻomau ka heleleʻi ʻana o ka mana kūʻai o ka nickel, a i kēia manawa ua hōʻike ka ʻāpana kālā ma lalo o 1% o ka uku palena palena palena pau hola pekelala. I ka makahiki 2018, ma kahi o 1.26 biliona mau nickel i hana ʻia ma ka hale minike ʻo Philadelphia a me Denver.
Paʻa 5-centimeter: ʻO ka 5-centimeter a i ʻole 5 GHz band kahi ʻāpana o ka lekiō lekiō SHF (microwave) i hoʻokaʻawale ʻia i ka honua no ka lekiō amatir a me nā ukali amelia hoʻohana ma ke kula kiʻekiʻe. Ma nā wahi ITU 1 a me 3, aia ka pae lekiō amatir ma waena o 5,650 MHz a me 5,850 MHz. Ma ka ʻāpana ITU 2, aia ka pae leo lekiō ma waena o 5,650 MHz a me 5,925 MHz. Hoʻonohonoho ʻia ka lawelawe satelite amateur 5,830 a 5,850 MHz, no nā loulou i lalo wale nō ma ke kumu kiʻekiʻe, a ua hāʻawi ʻia hoʻi 5,650 i 5,670 MHz, no nā loulou i luna wale nō ma ke kumu kumu ʻole no nā mea hoʻohana ʻē aʻe. Pono nā keʻena amateur e ʻae i ka hoʻoweliweli ʻino mai nā mea hoʻohana ISM e hana nei i ka bana. Aia ka pā i loko o ka laulā IEEE C Band.
Triclosan: ʻO Triclosan kahi lāʻau antibacterial a antifungal i loaʻa i kekahi o nā huahana mea kūʻai aku, e like me ka toothpaste, nā kopa, nā mea holoi, nā mea pāʻani, a me nā lāʻau hoʻomaʻemaʻe ʻoki lāʻau. He like ia i ka hoʻohana a me ka hana o ka hana i triclocarban. Kona efficacy ma ke ʻano he antimicrobial konohiki, ka makaʻu o ka antimicrobial ia'ku, a me kona hiki kūlana i hoʻohiolo hormonal hoʻomohala noho controversial. ʻImi nā noiʻi hou e hoʻomaopopo i kāna hopena i ka hopena o nā meaola a me ke olakino kaiapuni.
Methylchloroisothiazolinone: ʻO Methylchloroisothiazolinone , i kapa ʻia hoʻi me MCI , ʻo ia ka hui pū me ke ʻano S (C 2 HCl) C (O) N (CH 3 ). He paʻa keʻokeʻo e hoʻoheheʻe kokoke i ka mahana o ka lumi. ʻO ka hui kahi isothiazolinone, kahi papa o nā heterocycle i hoʻohana ʻia e like me nā biocides. Hoʻohana pinepine ʻia ʻo MCI me ka methylisothiazolinone, kahi hui i ʻike ʻia ʻo Kathon. Ua hoihoi ka isothiazolinones i ka nānā no ka mea hiki iā lākou ke hoʻopili i ka dermatitis.
Methylchloroisothiazolinone: ʻO Methylchloroisothiazolinone , i kapa ʻia hoʻi me MCI , ʻo ia ka hui pū me ke ʻano S (C 2 HCl) C (O) N (CH 3 ). He paʻa keʻokeʻo e hoʻoheheʻe kokoke i ka mahana o ka lumi. ʻO ka hui kahi isothiazolinone, kahi papa o nā heterocycle i hoʻohana ʻia e like me nā biocides. Hoʻohana pinepine ʻia ʻo MCI me ka methylisothiazolinone, kahi hui i ʻike ʻia ʻo Kathon. Ua hoihoi ka isothiazolinones i ka nānā no ka mea hiki iā lākou ke hoʻopili i ka dermatitis.
5-Chloro-αMT: ʻO 5-Chloro-α-methyltr Egyptamine ( 5-Chloro-αMT ), i ʻike ʻia ʻo PAL-542 , kahi hua i loaʻa i ka tryptamine e pili ana i ka α-methyltr Egyptamine (αMT) a ʻo kekahi wale nō o nā ʻelele hoʻokuʻu serotonin-dopamine i ʻike ʻia (SDRAs). . Ua noiʻi ʻia i loko o nā holoholona ma ke ʻano he lapaʻau kūpono no ka hilinaʻi ʻana o ka cocaine. ʻO nā kumukūʻai EC 50 o 5-chloro-αMT i ka hoʻonāukiuki ʻana i ka hoʻokuʻu in vitro o serotonin (5-HT), dopamine (DA), a me norepinephrine (NE) i nā synaptosome ʻiole i hōʻike ʻia ma ke ʻano he 16 nM, 54 nM, a me 3434 nM, me ka lakio NE / DA o 63.6 a me ka lakio DA / 5-HT o 3.38, e hōʻike ana he kikoʻī kikoʻī a kaulike SDRA ia. Eia nō naʻe, ua ʻike ʻia ʻo 5-chloro-αMT e hana ma ke ʻano he agonist piha ikaika o ka receptor 5-HT 2A , me kahi waiwai EC 50 o 6.27 nM a me kahi pono o 105%, a aneane ʻoiaʻiʻo e hana ma ke ʻano he agonist ikaika o nā serotonin ʻē aʻe pū kekahi.
5-Chloro-αMT: ʻO 5-Chloro-α-methyltr Egyptamine ( 5-Chloro-αMT ), i ʻike ʻia ʻo PAL-542 , kahi hua i loaʻa i ka tryptamine e pili ana i ka α-methyltr Egyptamine (αMT) a ʻo kekahi wale nō o nā ʻelele hoʻokuʻu serotonin-dopamine i ʻike ʻia (SDRAs). . Ua noiʻi ʻia i loko o nā holoholona ma ke ʻano he lapaʻau kūpono no ka hilinaʻi ʻana o ka cocaine. ʻO nā kumukūʻai EC 50 o 5-chloro-αMT i ka hoʻonāukiuki ʻana i ka hoʻokuʻu in vitro o serotonin (5-HT), dopamine (DA), a me norepinephrine (NE) i nā synaptosome ʻiole i hōʻike ʻia ma ke ʻano he 16 nM, 54 nM, a me 3434 nM, me ka lakio NE / DA o 63.6 a me ka lakio DA / 5-HT o 3.38, e hōʻike ana he kikoʻī kikoʻī a kaulike SDRA ia. Eia nō naʻe, ua ʻike ʻia ʻo 5-chloro-αMT e hana ma ke ʻano he agonist piha ikaika o ka receptor 5-HT 2A , me kahi waiwai EC 50 o 6.27 nM a me kahi pono o 105%, a aneane ʻoiaʻiʻo e hana ma ke ʻano he agonist ikaika o nā serotonin ʻē aʻe pū kekahi.
5-Chloro-αMT: ʻO 5-Chloro-α-methyltr Egyptamine ( 5-Chloro-αMT ), i ʻike ʻia ʻo PAL-542 , kahi hua i loaʻa i ka tryptamine e pili ana i ka α-methyltr Egyptamine (αMT) a ʻo kekahi wale nō o nā ʻelele hoʻokuʻu serotonin-dopamine i ʻike ʻia (SDRAs). . Ua noiʻi ʻia i loko o nā holoholona ma ke ʻano he lapaʻau kūpono no ka hilinaʻi ʻana o ka cocaine. ʻO nā kumukūʻai EC 50 o 5-chloro-αMT i ka hoʻonāukiuki ʻana i ka hoʻokuʻu in vitro o serotonin (5-HT), dopamine (DA), a me norepinephrine (NE) i nā synaptosome ʻiole i hōʻike ʻia ma ke ʻano he 16 nM, 54 nM, a me 3434 nM, me ka lakio NE / DA o 63.6 a me ka lakio DA / 5-HT o 3.38, e hōʻike ana he kikoʻī kikoʻī a kaulike SDRA ia. Eia nō naʻe, ua ʻike ʻia ʻo 5-chloro-αMT e hana ma ke ʻano he agonist piha ikaika o ka receptor 5-HT 2A , me kahi waiwai EC 50 o 6.27 nM a me kahi pono o 105%, a aneane ʻoiaʻiʻo e hana ma ke ʻano he agonist ikaika o nā serotonin ʻē aʻe pū kekahi.
5-Chloro-αMT: ʻO 5-Chloro-α-methyltr Egyptamine ( 5-Chloro-αMT ), i ʻike ʻia ʻo PAL-542 , kahi hua i loaʻa i ka tryptamine e pili ana i ka α-methyltr Egyptamine (αMT) a ʻo kekahi wale nō o nā ʻelele hoʻokuʻu serotonin-dopamine i ʻike ʻia (SDRAs). . Ua noiʻi ʻia i loko o nā holoholona ma ke ʻano he lapaʻau kūpono no ka hilinaʻi ʻana o ka cocaine. ʻO nā kumukūʻai EC 50 o 5-chloro-αMT i ka hoʻonāukiuki ʻana i ka hoʻokuʻu in vitro o serotonin (5-HT), dopamine (DA), a me norepinephrine (NE) i nā synaptosome ʻiole i hōʻike ʻia ma ke ʻano he 16 nM, 54 nM, a me 3434 nM, me ka lakio NE / DA o 63.6 a me ka lakio DA / 5-HT o 3.38, e hōʻike ana he kikoʻī kikoʻī a kaulike SDRA ia. Eia nō naʻe, ua ʻike ʻia ʻo 5-chloro-αMT e hana ma ke ʻano he agonist piha ikaika o ka receptor 5-HT 2A , me kahi waiwai EC 50 o 6.27 nM a me kahi pono o 105%, a aneane ʻoiaʻiʻo e hana ma ke ʻano he agonist ikaika o nā serotonin ʻē aʻe pū kekahi.
5-Chloro-αMT: ʻO 5-Chloro-α-methyltr Egyptamine ( 5-Chloro-αMT ), i ʻike ʻia ʻo PAL-542 , kahi hua i loaʻa i ka tryptamine e pili ana i ka α-methyltr Egyptamine (αMT) a ʻo kekahi wale nō o nā ʻelele hoʻokuʻu serotonin-dopamine i ʻike ʻia (SDRAs). . Ua noiʻi ʻia i loko o nā holoholona ma ke ʻano he lapaʻau kūpono no ka hilinaʻi ʻana o ka cocaine. ʻO nā kumukūʻai EC 50 o 5-chloro-αMT i ka hoʻonāukiuki ʻana i ka hoʻokuʻu in vitro o serotonin (5-HT), dopamine (DA), a me norepinephrine (NE) i nā synaptosome ʻiole i hōʻike ʻia ma ke ʻano he 16 nM, 54 nM, a me 3434 nM, me ka lakio NE / DA o 63.6 a me ka lakio DA / 5-HT o 3.38, e hōʻike ana he kikoʻī kikoʻī a kaulike SDRA ia. Eia nō naʻe, ua ʻike ʻia ʻo 5-chloro-αMT e hana ma ke ʻano he agonist piha ikaika o ka receptor 5-HT 2A , me kahi waiwai EC 50 o 6.27 nM a me kahi pono o 105%, a aneane ʻoiaʻiʻo e hana ma ke ʻano he agonist ikaika o nā serotonin ʻē aʻe pū kekahi.
ʻElima mau koho manawa serial-reaction manawa: ʻO ka hana manawa serial- reactive ʻelima mau koho (5CSRTT) kahi hana a ka lawena hana i hoʻohana ʻia i ka noiʻi psychological e loiloi i ka nānā ʻana i ka visuospatial a me ka impulsivity o ka motika i nā holoholona. Hana ʻia ka hana ma loko o kahi keʻena hana me ka liʻiliʻi o ʻelima mau puka (apertures) i hiki ke hoʻomālamalama, a me kahi pā meaʻai e hāʻawi i ka uku. Koi ʻia ka 5CSRTT i ka holoholona e hoʻomaopopo pono i kahi o nā puka ʻelima i hoʻomālamalama iki ʻia, ma o ka ihu ihu, i loaʻa ai kahi makana kō. Hoʻopili ʻia ka paʻakikī o ka hana e ka lōʻihi o ka manawa e hoʻomālamalama ai ka puka: ʻo kahi manawa hoʻomālamalama ʻoi aku ka manawa e pono ai ka holoholona e nānā nui, a ʻoi aku ka paʻakikī. Ma waena o kēlā me kēia hoʻokolokolo, aia kekahi manawa pōkole kahi e kāohi ai ka holoholona i nā pane āpau, a me nā pane ʻana i kēia wā i hui ʻia me kahi manawa pōkole a hoʻopaʻa ʻia ma ke ʻano he maikaʻi ʻole o ka kaohi.
5 cm KwK 39: ʻO ka 5 cm KwK 39 L / 60 (5 cm Kampfwagenkanone 39 L / 60) kahi pū pahu pahu 50 Kelemania i hoʻohana ʻia i ka wā o ke Kaua Honua ʻElua, ʻo ia hoʻi ka mea kaua nui o nā mamana hope loa o ka pahu Panzerkampfwagen III o ka pahu Kelemania mai Kēkēmapa 1941 a ʻoi. . Ua hana ʻia i ka wā i kū pono ai nā pahu T-34 a me KV-1 i kāhiko ʻia i ka hoʻonui mau ʻana i ka helu ma ka Hikina Hikina, ʻoiai ua kūleʻa hapa wale ʻia i kāna kuleana. Ma hope ua hakahaka ʻia e ka 7.5 cm KwK 40 L / 43.
ʻElima kala theorem: ʻO ka theorem kala ʻelima he hopena ia mai ke kumumanaʻo kiʻiona i hāʻawi ʻia i kahi mokulele i hoʻokaʻawale ʻia i nā wahi, e like me ka palapala politika o nā kalana o kahi mokuʻāina, hiki ke kala ʻia nā wahi me ka hoʻohana ʻole ʻana ma mua o ʻelima mau kala i ke ʻano i ʻaʻohe ʻelua mau ʻāina pili. loaʻa ka kala like.
5-ʻōiwix: I ka geometry ʻelima dimensional, kahi 5-orthoplex , a i ʻole 5-cross polytope, he polytope ʻelima dimensional me 10 vertices, 40 mau kihi, 80 mau helehelena triangle, 80 mau hunaola tetrahedron, 32 5-cell 4-alo.
5-ʻōiwix: I ka geometry ʻelima dimensional, kahi 5-orthoplex , a i ʻole 5-cross polytope, he polytope ʻelima dimensional me 10 vertices, 40 mau kihi, 80 mau helehelena triangle, 80 mau hunaola tetrahedron, 32 5-cell 4-alo.
5-ʻōiwix: I ka geometry ʻelima dimensional, kahi 5-orthoplex , a i ʻole 5-cross polytope, he polytope ʻelima dimensional me 10 vertices, 40 mau kihi, 80 mau helehelena triangle, 80 mau hunaola tetrahedron, 32 5-cell 4-alo.
ʻO 5-HT ka mea loaʻa: ʻO nā mea loaʻa ʻo 5-HT , nā mea loaʻa he 5-hydroxytr Egyptamine , a i ʻole nā mea loaʻa serotonin , kahi hui o nā mea loaʻa pū kekahi protein G a me nā kaha ion ligand-gated i loaʻa i nā ʻōnaehana kikowaena a me nā ʻaoʻao āpau. Hoʻopili lākou i nā neurotransmission excitatory a me inhibitory. Hoʻoulu ʻia nā mea hoʻolauna serotonin e ka neurotransmitter serotonin, e hana nei ma ke ʻano he ligand maoli.
5-cubus: I ka geometry ʻelima dimensional, he inoa 5-cubube no ka hypercube ʻelima dimensional me 32 piko, 80 lihi, 80 alo alo, 40 cubic cells, a me 10 tesseract 4-alo.
5-cubic waihona meli: ʻO ka meli 5-cubic a i ʻole honeycomb penteractic ʻo ia wale nō ka tessellation hoʻopiha piha ākea ma Euclidean 5-space. E hui ana ʻehā mau pahu 5 i kēlā me kēia ʻaoʻao cubic, a ua kapa ʻia ia ma ke ʻano he meli penteractic
5-cubic waihona meli: ʻO ka meli 5-cubic a i ʻole honeycomb penteractic ʻo ia wale nō ka tessellation hoʻopiha piha ākea ma Euclidean 5-space. E hui ana ʻehā mau pahu 5 i kēlā me kēia ʻaoʻao cubic, a ua kapa ʻia ia ma ke ʻano he meli penteractic
5D: E nānā paha ʻo 5D a i ʻole 5-D iā:
Δ-Decalactone: ʻO δ-Decalactone ( DDL ) kahi hui kemika, i hoʻonohonoho ʻia ma ke ʻano he lactone, kū maoli i nā hua a me nā huahana waiū ma nā meheu. Hiki ke kiʻi ʻia mai nā kumuwaiwai a me nā kumuwaiwai ʻelua. Hana ʻia, hana ʻia ia mai Baeyer – Villiger oxidation o delfone. Mai ka biomass, hiki ke hana ʻia ma o ka hydrogenation o 6-amyl-α-pyrone. He noi ʻo DDL i ka meaʻai, polymer, a me nā ʻoihana mahiʻai e hana i nā huahana nui.
5-Decyne: ʻO 5-Decyne , a i ʻike ʻia hoʻi ma ka inoa dibutylethyne , kahi ʻano alkyne me ke kolu paʻa ma kona kalima ʻelima (ʻo ka '5-' e hōʻike ana i kahi o ka palapala kolu i loko o ke kaulahao). ʻO C 10 H 18 kāna hana. ʻO kona mānoanoa ma 25 ° C a i ʻole nā ​​ʻano maʻamau ʻo 0.766 g / ml. ʻO ka kiko kupa he 177 ° C. ʻO ka awelika nui molar ʻo 138.25 g / mol.
5-dehydro-2-deoxyphosphogluconate aldolase: I loko o ka enzymology, kahi 5-dehydro-2-deoxyphosphogluconate aldolase kahi enzyme e catalyzed i ka hopena kemika 5-dehydro-2-deoxy-D-gluconate 6-phosphate glycerone phosphate + malonate semialdehyde
5-dehydro-2-deoxygluconokinase: I loko o ka enzymology, kahi 5-dehydro-2-deoxygluconokinase kahi enzyme e catalyzed i ka hopena kemika ATP + 5-dehydro-2-deoxy-D-gluconate ADP + 6-phospho-5-dehydro-2-deoxy-D-gluconate
5-dehydro-2-deoxyphosphogluconate aldolase: I loko o ka enzymology, kahi 5-dehydro-2-deoxyphosphogluconate aldolase kahi enzyme e catalyzed i ka hopena kemika 5-dehydro-2-deoxy-D-gluconate 6-phosphate glycerone phosphate + malonate semialdehyde